Dipotassium N-stearoyltyrosinate ameliorated pathological injuries in triple-transgenic mouse model of Alzheimer's disease

Dipotassium N-stearoyltyrosinate ameliorated pathological injuries in triple-transgenic mouse model of Alzheimer's disease

Recently, anandamide (AEA) analogues have been well recognized for its potent neuroprotective effects in counteracting the deterioration of Alzheimer's disease (AD) brains through multiple pathological processes. In our previous studies, dipotassium N-stearoyltyrosinate (NSTK), an AEA analogue...

Full description

Bibliographic Details
Main Authors:	Sha Liu, Shuang-Qi Tang, Heng-Jing Cui, Sha Yin, Ming Yin, Hong Zhao, Ling-Hua Meng, Ze-Jian Wang, Yang Lu
Format:	Article
Language:	English
Published:	Elsevier 2016-09-01
Series:	Journal of Pharmacological Sciences
Subjects:	Alzheimer's disease APPSWE/PS1M146V/TauP301L mouse model Dipotassium N-stearoyltyrosinate Animal behavior Neuroprotection
Online Access:	http://www.sciencedirect.com/science/article/pii/S1347861316301190

Similar Items

Phosphorylation of Tau at S422 is enhanced by Aβ in TauPS2APP triple transgenic mice
by: Fiona Grueninger, et al.
Published: (2010-02-01)

Regional vulnerability and spreading of hyperphosphorylated tau in seeded mouse brain
by: Jan R. Detrez, et al.
Published: (2019-07-01)

Growth Inhibitory Effects of Dipotassium Glycyrrhizinate in Glioblastoma Cell Lines by Targeting MicroRNAs Through the NF-κB Signaling Pathway
by: Gabriel Alves Bonafé, et al.
Published: (2019-05-01)

Quantitative <sup>1</sup>H Nuclear Magnetic Resonance Method for Assessing the Purity of Dipotassium Glycyrrhizinate
by: Yuan-Yuan Zhang, et al.
Published: (2021-06-01)

Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of APPSwe/PS1ΔE9 Transgenic Female Mice
by: Madilyn Coles, et al.
Published: (2020-12-01)

Dipotassium Glycyrrhizate Improves Intestinal Mucosal Healing by Modulating Extracellular Matrix Remodeling Genes and Restoring Epithelial Barrier Functions
by: Laura Stronati, et al.
Published: (2019-04-01)

Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways
by: Miren Ettcheto, et al.
Published: (2017-10-01)

The Cyanthin Diterpenoid and Sesterterpene Constituents of Hericium erinaceus Mycelium Ameliorate Alzheimer’s Disease-Related Pathologies in APP/PS1 Transgenic Mice
by: Tsai-Teng Tzeng, et al.
Published: (2018-02-01)

Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease
by: Monica Garcia-Alloza, et al.
Published: (2006-12-01)

Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimer’s disease in metabolically stressed APPswe/PS1dE9 mice
by: Miren Ettcheto, et al.
Published: (2021-07-01)

Effects of digestate, magnesium sulfate, and dipotassium hydrogen phosphate/potassium dihydrogen phosphate on microalga, <i>Scenedesmus dimorphus<i>
by: HE, ZHUOHUI JOE
Published: (2016)

Naringin Enhances CaMKII Activity and Improves Long-Term Memory in a Mouse Model of Alzheimer’s Disease
by: Lian-Feng Zhang, et al.
Published: (2013-03-01)

Impact de l’infection à Helicobacter pylori sur la maladie d’Alzheimer
by: Baudron Roubaud, Claire
Published: (2014)

Functional cholinergic damage develops with amyloid accumulation in young adult APPswe/PS1dE9 transgenic mice
by: Eva Machová, et al.
Published: (2010-04-01)

Electron spin resonance of X- and Y- irradiated potassium difluoromalonate and electron paramagnetic resonance of copper (II) complex with trifluoroacetate ligands
by: Mustafa, Mohammed Rafi
Published: (2011)

Santacruzamate A Ameliorates AD-Like Pathology by Enhancing ER Stress Tolerance Through Regulating the Functions of KDELR and Mia40-ALR in vivo and in vitro
by: Lei Chen, et al.
Published: (2019-03-01)

Quantification of tapentadol in rat plasma by HPLC with photo diode array detection: Development and validation of a new methodology
by: B. Mohammed Ishaq, et al.
Published: (2017-06-01)

Effector function of anti-pyroglutamate-3 Aβ antibodies affects cognitive benefit, glial activation and amyloid clearance in Alzheimer’s-like mice
by: Helen Crehan, et al.
Published: (2020-01-01)

Age-related disturbances in DNA (hydroxy)methylation in APP/PS1 mice
by: Chouliaras Leonidas, et al.
Published: (2018-12-01)

Co-Treatment with the Herbal Medicine SIP3 and Donepezil Improves Memory and Depression in the Mouse Model of Alzheimer’s Disease
by: Chin, Y.-W, et al.
Published: (2022)

Doubly Phosphorylated Peptide Vaccines to Protect Transgenic P301S Mice against Alzheimer’s Disease Like Tau Aggregation
by: Monique Richter, et al.
Published: (2014-07-01)

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization
by: Elena Sánchez-López, et al.
Published: (2018-03-01)

Self-nanomicellizing solid dispersion of edaravone: part II: in vivo assessment of efficacy against behavior deficits and safety in Alzheimer’s disease model
by: Parikh A, et al.
Published: (2018-07-01)

Amelioration of Behavioral Impairments and Neuropathology by Antiepileptic Drug Topiramate in a Transgenic Alzheimer’s Disease Model Mice, APP/PS1
by: Brice Ayissi Owona, et al.
Published: (2019-06-01)

N-linoleyltyrosine exerts neuroprotective effects in APP/PS1 transgenic mice via cannabinoid receptor-mediated autophagy
by: Chun-mei Long, et al.
Published: (2021-12-01)

Using phosphate to increase feeding consumption in termite Coptotermes formosanus
by: Hiroto Suhara
Published: (2020-12-01)

DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice
by: C.R. Hooijmans, et al.
Published: (2009-03-01)

Sex-Related Motor Deficits in the Tau-P301L Mouse Model
by: Luana Cristina Camargo, et al.
Published: (2021-09-01)

Increased misfolding and truncation of tau in APP/PS1/tau transgenic mice compared to mutant tau mice
by: Céline Héraud, et al.
Published: (2014-02-01)

Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice
by: Dickson Dennis W, et al.
Published: (2011-10-01)

Biochemical distribution of tau protein in synaptosomal fraction of transgenic mice expressing human P301L tau
by: Naruhiko eSahara, et al.
Published: (2014-03-01)

Unraveling Early Signs of Navigational Impairment in APPswe/PS1dE9 Mice Using Morris Water Maze
by: Smitha Karunakaran
Published: (2020-12-01)

Autophagy is increased following either pharmacological or genetic silencing of mGluR5 signaling in Alzheimer’s disease mouse models
by: Khaled S. Abd-Elrahman, et al.
Published: (2018-04-01)

Selenomethionine Ameliorates Neuropathology in the Olfactory Bulb of a Triple Transgenic Mouse Model of Alzheimer’s Disease
by: Zhong-Hao Zhang, et al.
Published: (2016-09-01)

Long-Term Caloric Restriction Attenuates β-Amyloid Neuropathology and Is Accompanied by Autophagy in APPswe/PS1delta9 Mice
by: Luisa Müller, et al.
Published: (2021-03-01)

Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning
by: Florian Eckenweber, et al.
Published: (2020-07-01)

Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling
by: Lei Li, et al.
Published: (2020-02-01)

Abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of Alzheimer’s disease
by: Yang Bai, et al.
Published: (2017-11-01)

Cornel Iridoid Glycoside Protects Against STAT1-Dependent Synapse and Memory Deficits by Increasing N-Methyl-D-aspartate Receptor Expression in a Tau Transgenic Mice
by: Denglei Ma, et al.
Published: (2021-05-01)

YY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuates neurodegenerative changes induced by β-amyloid (1-42) or double transgenic overexpression of APP and PS1 via inhibition of cyclooxygenase-2
by: Zheng-Yi Li, et al.
Published: (2017-04-01)